Showing results (21-30 of 90) with videos related to
Sort By:
Pageof 9
Annals of Translational Medicine|March 14, 2022
Analysis of cancer-promoting genes related to chemotherapy resistance in esophageal squamous cell carcinomaFeng Xie, Donglei Zhang, Xiaoqing Qian, et al.Journal of Medicinal Chemistry|January 3, 2018
Structural Modification of Natural Product Tanshinone I Leading to Discovery of Novel Nitrogen-Enriched Derivatives with Enhanced Anticancer Profile and Improved Drug-like PropertiesChunyong Ding, Qianting Tian, Jie Li, et al.Organic Letters|July 10, 2013
Overcoming synthetic challenges of oridonin A-ring structural diversification: regio- and stereoselective installation of azides and 1,2,3-triazoles at the C-1, C-2, or C-3 positionChunyong Ding, Yusong Zhang, Haijun Chen, et al.Tetrahedron Letters|March 6, 2013
Efficient Synthesis of ESI-09, A Novel Non-cyclic Nucleotide EPAC AntagonistHaijun Chen, Chunyong Ding, Christopher Wild, et al.Journal of Medicinal Chemistry|May 10, 2007
Synthesis and pharmacological evaluation of 6,7-indolo/thiazolo-morphinans--further SAR of levorphanolAo Zhang, Fuying Li, Chunyong Ding, et al.Cancer Letters|July 9, 2016
A new oridonin analog suppresses triple-negative breast cancer cells and tumor growth via the induction of death receptor 5Jing Wu, Ye Ding, Chuan-Huizhi Chen, et al.European Journal of Medicinal Chemistry|February 19, 2013
Fragment-based drug design and identification of HJC0123, a novel orally bioavailable STAT3 inhibitor for cancer therapyHaijun Chen, Zhengduo Yang, Chunyong Ding, et al.Toxicology and Applied Pharmacology|November 10, 2020
A novel salviadione derivative, compound 15a, attenuates diabetes-induced renal injury by inhibiting NF-κB-mediated inflammatory responsesLi Li, Chunyong Ding, Chunpeng Zou, et al.Bioorganic Chemistry|June 3, 2026
Palladium-catalyzed C(sp<sup>3</sup>)-H arylation of celastrol: synthesis and pharmacological evaluation of C-21/28 arylated derivativesFan-Fan Shang, Mengnisa Seydimemet, Zhengyuan Wang, et al.Neuro-Oncology|October 11, 2017
Selective BCL-XL inhibition promotes apoptosis in combination with MLN8237 in medulloblastoma and pediatric glioblastoma cellsJane Levesley, Lynette Steele, Anke Brüning-Richardson, et al.Pageof 9